Seroquel

Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications

WILMINGTON, Del., June 10 /PRNewswire/ -- Today, the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee conducted a review of the efficacy and safety of supplemental new drug applications (sNDAs) for SEROQUEL (quetiapine fumarate) tablets proposed for the acute tr...

FDA Panel OKs Antipsychotic Seroquel for Children

The drug, and others like it, have been linked to certain health risks, experts note,, WEDNESDAY, June 10 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Wednesday voted "overwhelmingly" that Seroquel, a powerful antipsychotic drug, be approved to treat schiz...

For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms

Lamictal Will Retain Decision Resources' Clinical Gold Standard Status for Bipolar Depression, According to a New Report from Decision Resources WALTHAM, Mass., April 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

WILMINGTON, Del., April 8 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for SEROQUEL XR (quetiapine fumarate) extended-relea...

FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications

WILMINGTON, Del., April 8 /PRNewswire-FirstCall/ -- Today, the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for SEROQUEL XR (quetiapine fumarate) extended-relea...

FDA Panel Snubs Seroquel as 1st Choice Depression Treatment

Safety concerns mean the drug should only be used when other medications don't work, advisers say WEDNESDAY, April 8 (HealthDay News) -- In a unanimous vote, a U.S. Food and Drug Administration advisory panel determined Wednesday that AstraZeneca's antipsychotic drug Seroquel has too ...

FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site

WILMINGTON, Del., April 3 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) is aware that earlier today, the US Food and Drug Administration (FDA) posted to its web site -- and subsequently removed -- briefing documents for the April 8, 2009 Psychopharmacologic Drugs Advisory Committee (PDAC) m...

AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression

SEROQUEL XR is Now Approved to Treat the Depressive, Manic, and Mixed Episodes of Bipolar Disorder WILMINGTON, Del., Feb. 23 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today launched its once-daily SEROQUEL XR(R) (quetiapine fumarate) Extended-Release Tablets for the acute treat...

A Drug That Carries a Lower Risk of Weight Gain Than AstraZeneca's Seroquel and Has Antimanic and Antidepressant Effects Would Earn a 30 Percent Patient Share in Bipolar Disorder Treatment

Seroquel's Successor, Seroquel XR, Will Earn a 16 Percent Patient Share in the Bipolar Disorder Market by 2016, According to a New Report from Decision Resources WALTHAM, Mass., April 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advis...

Astra Zeneca's Seroquel Gets FDA Approval For Schizophrenia

Seroquel(quetiapine) has been approved by the FDA for treating both manic and depressive forms of bipolar disorder, Astra Zeneca announced on Monday. The drug was// previously used for treating the manic form of the disease and schizophrenia, as are Zyprexa(Eli Lilly & Co), Risperdal(J&J) and Abili...

Seroquel in Medical Technology

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines

WILMINGTON, Del., May 8 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets to seek approval for the trea...

New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting

- Studies Evaluated Improvement in Symptoms Both in the Short and Long Term - WILMINGTON, Del., May 5 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced new study data on SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets for the treat...

AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression

WILMINGTON, Del., Jan. 2 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release...

New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia

--Study Used To Support FDA Approval of SEROQUEL XR-- WILMINGTON, Del., May 22, 2007 /PRNewswire-FirstCall/ -- AstraZeneca today announced that two analyses from a large-scale study that investigated the efficacy of SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, a once-daily medic...

SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia

... Drug Administration (FDA) has approved once-daily seroquel XR(TM) (quetiapine fumarate) Extended-Release Tabl... adult patients. On May 17, 2007, the FDA approved seroquel XR for the acute treatment of schizophrenia in adu... patients with schizophrenia who were treated with seroquel XR experienced a significantly longer time to rela...

INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients

...of acutely ill, hospitalized patients, compared to seroquel and placebo after two weeks of treatment (p 0.00...f schizophrenia were randomized to receive INVEGA, seroquel or placebo. These patients were either hospitalize...on to increase the dose to 12 mg/day on day eight. seroquel was titrated to 600 mg/day by day five with an opt...

Seroquel Sustained Release Schizophrenia Data Presented at ECP Congress in Madrid

... LONDON, March 18, 2007-AstraZeneca today announced clinical trial data for seroquel sustained release formulation (quetiapine fumarate sustained release), at t...ginal formulation quetiapine, there were no significant differences between seroquel sustained release formulation and the original formulation quetiapine in PA...

Seroquel in Biological News

FDA Warns About Antipsychotic Drugs and Elderly

... to patients receiving a placebo (sugar pill). Today's advisory applies to such antipsychotic drugs as Abilify (aripiprazole), Zyprexa (olanzapine), seroquel (quetiapine), Risperdal (risperidone), Clozaril (clozapine) and Geodon (ziprasidone). Symbyax, which is approved for treatment of depressive episodes ...

Seroquel in Biological Technology

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

WILMINGTON, Del., Oct. 10 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR(R) (quetiapine fumarate) Extended-Release Tablets for the acute treatment of the depressive episodes associated with ...

Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca

AstraZeneca's CEO to be Deposed in London on Friday, June 20, 2008 NEW YORK, June 19 /PRNewswire/ -- Weitz & Luxenberg, PC, one of the leading plaintiffs' litigation law firms in America, filed a lawsuit today against pharmaceutical giant AstraZeneca on behalf of a New York City Fire Depart...

AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder

WILMINGTON, Del., Feb. 29 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets to seek approva...

Cadient Group Brings Home the Gold at 2008 Aster Awards

...ecial Video Production Cadient Group was recognized with the gold award in the Special Video Production category for its work on AstraZeneca's seroquel Immersive Patient Experience campaign. -- Gold Award - Total Advertising Campaign Cadient Group and Shire's Vyvanse Online Launch Campaign w...

New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated

...umazanil / gabapentin / hydroyzine; Hythiam); glutamatergic; non-NMDA; kainate; AMPA; CB-1; Acomplia (rimonabant; Sanofi-Aventis); SSRI; dopaminergic; seroquel (quetiapine; AstraZeneca); NPY; NK; CRH. About MedPredict MedPredict ( http://www.medpredict.com ) maintains a proprietary database of over 1,000 ...

Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer

... AstraZeneca's seroquel Emerges as the Antipsychotic of Choice in All Line...and atypical antipsychotics, such as AstraZeneca's seroquel (95 percent), as well as the recommended treatment... alter physician use." The report also finds that seroquel has gained ground among both psychiatrists and PCP...